Macula Society Research Grant

The purpose of the MSRG program is to provide funding for clinically relevant research into macular or retinal vascular diseases. Pilot projects with the potential to obtain additional external funding and projects coordinating the efforts of the general membership are preferred. Projects that already receive or are expected to receive $50,000 or more from other sources are not eligible for the Macula Society Research Grant Program. Members who received a research grant in the past three years are not eligible.

2020-2021 Research Grant Application

 

Macula Society Research Grant Submission Site is Closed.

Click here for past recipients of a Retina Research Foundation grant who are also ineligible to apply for the MSRG.
Research Grant Overview
  1. We have one grant this year available to support research endeavors of the members of the Macula Society. Retina Research Foundation generously supports one grant of $30k The funding of a proposal will be determined by the Research Committee depending on several criteria based upon(i) the project design (ii) the project feasibility (iii) the project significance. The ranking will then be presented to the Executive Committee and distribution of the final funding determined. 
  1. The due date for applications will be January 2, 2021 at 11:59PM EST on the Macula Society web site. These should be submitted on line to allow easy transmittal to the various research committee members. The Macula Society Office will then disseminate the received applications to Committee members who will evaluate and rank them and make recommendations to the Chair for funding. These summaries will then be returned both to the Chair and Society secretary who will tally these numerical scores from which the final recommendations will be made. The funds will be released and the winner will be announced at the time of the 2021 Annual Meeting. 
  1. No member of the Executive Committee or Research Committee may apply for this award during their time of service. 
  1. Due to monetary restrictions, past Retina Research Foundation Award recipients are ineligible for this award. Click here for past recipients of a Retina Research Foundation grant who are ineligible to apply for the MSRG, or you may review the list on the Research Foundation site, http://retinaresearchfnd.org/research-programs/awardhistory/ 
 Funding Guidelines: 
  1. The proposed research must have the potential of increasing the understanding of macular or retinal diseases. Grant proposals facilitating collaboration among the Macula Society members to study a particular disease are encouraged as well. Research receiving partial funding from sources additional to this MSRG award is also eligible, as the Macula Society believes that their support may encourage others to fund research. 
  1. Funds are to be applied to equipment, supplies, and non-physician salary support. 
  1. Research must conform to accepted standards of conduct (e.g., ARVO Guidelines for Use of Animals in Research), and is to receive institutional approval by the appropriate review committees (e.g., Animal Care Committee, Human Research Review Committee, etc.). 
  1. The duration of the research project must not exceed 18 months. Research monies not disbursed during this time will be returned to the Macula Society. 
  1. The firm deadline for receipt of an application is listed above. All applications must be submitted online through the Macula Society web site, www.maculasociety.org. 
  1. Members of the Grant Application Review Committee consist of the Macula Society Research and Education Committee, who, as members, are ineligible for consideration of these awards. Members of the Executive Committee are also ineligible for consideration. 
  1. Award recipients must acknowledge the support of the Macula Society Research Award Grant Program on all papers, presentations, and abstracts regarding the supported research. 
  1. Each recipient must present their research project to the Macula Society within two years of receiving an award. The presentation will be given in a specially designated section of the Annual Meeting of the Macula Society. 
  1. An audit of funds may be requested by the Macula Society at the completion of the project. 
Macula Society Research Committee
c/o Stacy Singerman
3401 Enterprise Parkway, Suite 310
Beachwood, Ohio 44122
Phone: 216.839.4949 Fax: 216.831.8221

    Research Grant Recipients

    2021

    The Mills and Margaret Cox Macula Society Research Project

    $30,000

    Dr. Prithvi Mruthyunjaya, Byers Eye Institute at Stanford University

    Title: “Aqueous Humor Proteomic analysis to detect targetable diagnostic biomarkers in uveal melanoma”

    		 Prithvi Mruthyunjaya, MD, MHS - The American Society of Retina Specialists

    2020
    The Regeneron Macula Society Grant
    $37,500
    Jasmine H. Francis, MD, FACS
    Memorial Sloan Kettering Cancer Center
    Title: Noninvasive Molecular Profiling of Uveal Melanoma with Cell-free DNA Analysis
    		 Swept-Source Optical Coherence Tomography Features of Choroidal Nevi - ScienceDirect
    The Regeneron Macula Society Grant
    $37,500
    Deeba Husain, MD
    Memorial Sloan Kettering Cancer Center
    Title: Role of Tissue Metabolomics in Age-Related Macular Degeneration
     

    RRF Mills and Margaret Cox Macula Society Research Project

    $30,000
    Kathryn L. Pepple, MD, PhD
    Emory Eye Center
    Title: Retinal Microglia and Innate Lymphoid Cells in Post-Infectious Uveitis

    2019
    The Regeneron Macula Society Grant
       
    $37,500
    Glenn Yiu, MD
    University of California, Davis
    Title: Host immune responses to CRISPR-based Genome Editing of VEGF-A using AAV vectors

    RRF Mills and Margaret Cox Macula Society Research Project

    $30,000
    Stephen Yeh, MD
    Emory Eye Center
    Title: Ophthalmic Surveillance of Emerging Infectious Diseases within Sub-Saharan African and Southeast Asian Outbreak Zones

    The Regeneron Macula Society Grant

    $37,500
    Theodore Smith, MD
    Icahn School of Medicine of Mount Sinai
    Title: Fluorescence lifetime imaging in Age-related macular degeneration (AMD)

    2018
    The Mills and Margaret Cox Macula Society Research Project
    $30,000
    Cagri G. Besirli; MD, PhD
    Department of Ophthalmology and Visual Sciences, University of Michigan
    Title: The Role of HK2 in Photoreceptor Metabolism and Survival
     
    The Macula Society Research Grant supported by Regeneron
    $37,500
    Shlomit Schaal MD
    UMASS Medical School
    Title: Cone Photoeceptor defects in Retinal Degenerative Diseases
     
    The Macula Society Research Grant supported by Regeneron
    $37,500
    Naresh Mandava MD
    University of Colorado
    Title: Protein Biomarkers and Biological Pathways in the Recticular Pseudodrusen Phenotype of Age-Related Macular Degeneration

    2017
    M.E. Hartnett
    Novel Gene Therapy to Regulate Pathologic Neovascularization in AMD

    2016
    Christine A. Curcio, PhD
    Visualizing organelles in human retinal pigment epithelium by 3-dimensional electron microscopy

    2015
    Robyn Heather Guymer, MD
    The role of reduced phagocytosis in the pathogenesis of AMD

    2013
    Demetrios Vavvas, MD
    Role of RIP3 Kinase in Inflammation and Photoreceptor Cell Loss

    2012

    Kang Zhang, M.D.
    Using AMD Patient iPSCs for RPE Differentiation and Disease Modeling

    Amani Fawzi, M.D.
    Platform for long-term Delivery of Anti-Angiogenic Peptides for Intravitreal Treatment of Neovascular Eye Disease

    Milam A. Brantley, Jr., M.D., PhD.
    Small molecule-mediated differential expression of HTRA1 and ARMS2 to elucidate gene function in AMD

    2011

    Stephen Tsang, MD, PhD
    Genetic and Environmental Factors in AMD

    Click here for a link to the report on youtube.

    		 tsang

    Stephen Jae Kim, MD
    Safety, Pharmacokinetics, and Efficacy of Celecoxib and Valdecoxib after Intraocular Administration for Macular Edema

    		 kim

    2010

    J. William Harbour, MD
    Development of a blood test to diagnose uveal melanoma

    		 harbour

    2009

    Rajendra S. Apte, MD
    Wnt Signaling in Choroidal Neovascularization

    		 Apte

    Lloyd P. Aiello, MD
    Treatment with Oral Rosiglitazone to Prevent the Progression of Diabetic Retinopathy in eyes at high risk of developing proliferative disease

    		 AIELLO

    2007

    Paul Sternberg, MD
    Plasma proinflammatory biomarkers in patients with age-related macular degeneration

    		 sternberg

    Jose Pulido, MD
    Activation State fo Immune Cells in the Human Choriod

    		 PULIDOJOSE

    Member Login

    Forgot Login?
    Officers
    President
    Mark W. Johnson, MD
    Executive Secretary and Founder:
    Lawrence J. Singerman, MD
    President-Elect:
    Glenn J. Jaffe, MD
    Secretary:
    Daniel F. Martin, MD
    Treasurer:
    SriniVas Sadda, MD
    Committee Chairs
    Awards:
    Joan W. Miller, MD
    By-Laws:
    Adrienne W. Scott, MD
    Credentials:
    Dean Eliott, MD
    Endowment Committee: 
    Paul Sternberg, Jr.
    Meeting Planning:
    Julia A. Haller, MD
    Nominating:
    Judy E.Kim, MD
    Program:
    Anita Agarwal, MD
    Research:
    Mary Elizabeth Hartnett, MD
    Website:
    Richard F. Spaide, MD
    International Membership:
    Robin H. Guymer, AM, MBBS, PhD
    Young Member Representative:
    Nadia K. Waheed, MD
    Past Presidents
    Arnall Patz, MD
    J. Donald M. Gass, MD
    Morton F. Goldberg, MD
    Robert C. Watzke, MD
    Stephen J. Ryan, MD
    John G. Clarkson, MD
    David H. Orth, MD
    Alexander J. Brucker, MD
    Lee M. Jampol, MD
    Thomas M. Aaberg, MD
    Travis A. Meredith, MD
    Kurt A. Gitter, MD
    William F. Mieler, MD
    Daniel Finkelstein, MD
    Lawrence A. Yannuzzi, MD
    Evangelos S. Gragoudas, MD
    Jerry A. Shields, MD
    Michael L. Klein, MD
    Emily Y. Chew, MD
    Mark S. Blumenkranz, MD
    Neil M. Bressler, MD
    Paul Sternberg, Jr., MD
    M. Gilbert Grand, MD
    Andrew P. Schachat, MD
    James C. Folk, MD
    H. Richard McDonald, MD
    Joan W. Miller, MD
    Immediate Past President
    Carol L. Shields, MD

    Conference Management Software by X-CD Technologies Inc.